Signal-Induced Regulation of Alternative RNA Processing

替代 RNA 加工的信号诱导调节

基本信息

  • 批准号:
    10598066
  • 负责人:
  • 金额:
    $ 60.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-09 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary The ultimate goal of this project is to understand the interplay of cell signaling and RNA processing in shaping cellular gene expression and function. The specific focus of the current funding period is in unraveling the regulatory connections that exist between signaling pathways and RNA processing events, and the RNA binding proteins (RBPs) that maintain these connections. Decades of work have revealed that cell signaling pathways are central to controlling cellular function in response to environmental cues. Similarly, all of the steps of RNA processing, including alternative splicing, alternative polyadenylation and regulated mRNA stability, can be regulated to dictate the identity or abundance of the final mRNA and proteins. Historically, most work on the impact of cell signaling on gene expression has focused on the regulation of transcription. Therefore, how cell signaling impinges on the various mechanisms of RNA processing, and conversely, how RNA processing shapes the cellular response to environmental challenges, remain largely unexplored areas of research that are critical to our broad understanding of cellular activity. T cell activation provides an excellent a model system for complex cellular responses, as multiple signaling pathways are triggered downstream of antigen engagement and act, individually and cooperatively, to induce T cell effector functions. It has been well documented that T cell activation leads to changes in alternative splicing, polyadenylation and mRNA stability. Moreover, changes in these RNA processing events impact additional signaling pathway such as apoptosis and inflammation, which are critical secondary responses to T cell activation. However, many questions regarding the regulatory connections between RNA processing and signaling remain, including identifying the RBPs that link signaling to RNA processing, understanding the functional impact of processing events triggered by one signal on other pathways, and determining how individual RBPs coordinate multiple steps of RNA processing. This proposal will address these unanswered questions of signal-induced RNA processing by leveraging recent results and systems to determine how alternative splicing controls apoptosis and interferon responsive signaling in activated T cells, the proteins that control alternative polyadenylation and mRNA stability in response to T cell signaling, and a potential new mechanism for the regulation of translation by the RBP CELF2. Together these studies will provide novel insight regarding the interplay of signaling and RNA processing in shaping cellular function during T cell activation. Since the signaling pathways studied here are related to cell growth and death, the insight gained in these studies will be broadly applicable far beyond T cell biology. In addition, these studies will reveal new paradigms regarding the molecular mechanisms by which RBPs coordinately control multiple steps in RNA processing. Thus, results from these experiments will significantly increase the general understanding of the mechanisms that control proteome expression and cellular function in response to environmental cues.
项目摘要 这个项目的最终目标是了解细胞信号和RNA处理在成形过程中的相互作用。 细胞基因的表达和功能。当前供资期间的具体重点是解开 存在于信号通路和RNA加工事件之间的调节连接,以及RNA 维持这些连接的结合蛋白(RBP)。数十年的研究表明,细胞信号 通路是控制细胞功能以响应环境提示的中心。同样,所有的 RNA加工的步骤,包括选择性剪接、选择性聚腺苷酸化和受调控的mRNA 稳定性,可以调节以决定最终的信使核糖核酸和蛋白质的特性或丰度。从历史上看, 大多数关于细胞信号对基因表达的影响的工作都集中在转录调控上。 因此,细胞信号如何影响RNA加工的各种机制,反过来,又是如何 RNA处理塑造细胞对环境挑战的反应,在很大程度上仍然是尚未探索的领域 对我们广泛了解细胞活动至关重要的研究。T细胞活化提供了一种极好的 复杂细胞反应的模型系统,因为多个信号通路在下游被触发 抗原结合,单独和协同作用,诱导T细胞效应器功能。一切都很好 研究证明,T细胞的激活会导致选择性剪接、多聚腺苷酸化和mRNA稳定性的变化。 此外,这些RNA加工事件的变化会影响额外的信号通路,如细胞凋亡 以及炎症,这是对T细胞激活的关键次级反应。然而,许多问题 关于RNA处理和信号之间的调节联系仍然存在,包括识别 将信令与RNA处理联系起来的限制性商业惯例,了解处理事件的功能影响 由其他路径上的一个信号触发,并确定单个RBP如何协调以下多个步骤 RNA处理。这项提案将通过以下方式解决这些尚未回答的信号诱导RNA处理问题 利用最新结果和系统确定替代剪接如何控制细胞凋亡和干扰素 激活的T细胞中的反应信号--控制交替多聚腺苷化和mRNA的蛋白质 对T细胞信号的响应的稳定性,以及一种潜在的新的机制来调节翻译 RBP CELF2.总之,这些研究将为信号和RNA的相互作用提供新的见解 在T细胞激活过程中塑造细胞功能的过程。因为这里研究的信号通路是 与细胞生长和死亡有关,这些研究中获得的见解将广泛适用于T细胞以外的领域 生物学。此外,这些研究将揭示关于分子机制的新范式 限制性商业惯例协调控制RNA加工中的多个步骤。因此,这些实验的结果将 显著提高了对控制蛋白质组表达和 细胞对环境提示作出反应的功能。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing.
HNRNP K和NS1-BP在流感和人mRNA剪接中的共调节活性。
  • DOI:
    10.1038/s41467-018-04779-4
  • 发表时间:
    2018-06-19
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Thompson MG;Muñoz-Moreno R;Bhat P;Roytenberg R;Lindberg J;Gazzara MR;Mallory MJ;Zhang K;García-Sastre A;Fontoura BMA;Lynch KW
  • 通讯作者:
    Lynch KW
Functional and Mechanistic Interplay of Host and Viral Alternative Splicing Regulation during Influenza Infection.
HnRNP L represses cryptic exons.
  • DOI:
    10.1261/rna.065508.117
  • 发表时间:
    2018-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    McClory SP;Lynch KW;Ling JP
  • 通讯作者:
    Ling JP
Structural basis for high-order complex of SARNP and DDX39B to facilitate mRNP assembly.
  • DOI:
    10.1016/j.celrep.2023.112988
  • 发表时间:
    2023-08-29
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
  • 通讯作者:
The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.
  • DOI:
    10.1111/imr.13018
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    8.7
  • 作者:
    Blake D;Lynch KW
  • 通讯作者:
    Lynch KW
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISTEN W LYNCH其他文献

KRISTEN W LYNCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISTEN W LYNCH', 18)}}的其他基金

High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators
用于分析选择性剪接和剪接调节器的高通量分析
  • 批准号:
    9797508
  • 财政年份:
    2019
  • 资助金额:
    $ 60.79万
  • 项目类别:
Molecular Mechanisms and Signal-Induced Regulation of Alternative Splicing
选择性剪接的分子机制和信号诱导调控
  • 批准号:
    10217584
  • 财政年份:
    2016
  • 资助金额:
    $ 60.79万
  • 项目类别:
Signal-Induced Regulation of Alternative RNA Processing
替代 RNA 加工的信号诱导调节
  • 批准号:
    10400112
  • 财政年份:
    2016
  • 资助金额:
    $ 60.79万
  • 项目类别:
Molecular Mechanisms and Signal-Induced Regulation of Alternative Splicing
选择性剪接的分子机制和信号诱导调控
  • 批准号:
    9271211
  • 财政年份:
    2016
  • 资助金额:
    $ 60.79万
  • 项目类别:
Signal-Induced Regulation of Alternative RNA Processing
替代 RNA 加工的信号诱导调节
  • 批准号:
    10201033
  • 财政年份:
    2016
  • 资助金额:
    $ 60.79万
  • 项目类别:
Molecular Mechanisms and Signal-Induced Regulation of Alternative Splicing
选择性剪接的分子机制和信号诱导调控
  • 批准号:
    9913561
  • 财政年份:
    2016
  • 资助金额:
    $ 60.79万
  • 项目类别:
Mechanisms and consequences of CELF2 regulation in T cell development
T 细胞发育中 CELF2 调节的机制和后果
  • 批准号:
    8916790
  • 财政年份:
    2012
  • 资助金额:
    $ 60.79万
  • 项目类别:
Mechanisms and consequences of CELF2 regulation in T cell development
T 细胞发育中 CELF2 调节的机制和后果
  • 批准号:
    8525408
  • 财政年份:
    2012
  • 资助金额:
    $ 60.79万
  • 项目类别:
Mechanisms and consequences of CELF2 regulation in T cell development
T 细胞发育中 CELF2 调节的机制和后果
  • 批准号:
    8723862
  • 财政年份:
    2012
  • 资助金额:
    $ 60.79万
  • 项目类别:
Mechanisms and consequences of CELF2 regulation in T cell development
T 细胞发育中 CELF2 调节的机制和后果
  • 批准号:
    8410141
  • 财政年份:
    2012
  • 资助金额:
    $ 60.79万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 60.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了